2023 - Research.com Microbiology in Germany Leader Award
Stefan Niemann spends much of his time researching Mycobacterium tuberculosis, Genetics, Tuberculosis, Mycobacterium tuberculosis complex and DNA profiling. His studies deal with areas such as Drug resistance, Microbiology, Whole genome sequencing and Genotype as well as Mycobacterium tuberculosis. His Drug resistance research is multidisciplinary, incorporating perspectives in Pyrazinamide and Rifampicin.
His Tuberculosis research includes elements of Evolutionary biology, Population genetics, Immunology and Virology. In his study, which falls under the umbrella issue of Mycobacterium tuberculosis complex, Antibacterial agent is strongly linked to Isoniazid. His work in DNA profiling covers topics such as Genetic marker which are related to areas like Genotyping Techniques.
Stefan Niemann mainly focuses on Mycobacterium tuberculosis, Tuberculosis, Mycobacterium tuberculosis complex, Genetics and Drug resistance. The Mycobacterium tuberculosis study combines topics in areas such as Virology, Whole genome sequencing, Typing, Microbiology and Genotype. The various areas that Stefan Niemann examines in his Tuberculosis study include Multiple drug resistance, Molecular epidemiology, Immunology and Internal medicine.
His Mycobacterium tuberculosis complex study combines topics in areas such as Genetic diversity, Genotyping, Mycobacterium and Single-nucleotide polymorphism. His Genetics study frequently draws connections to other fields, such as Mycobacterium bovis. His study looks at the relationship between Drug resistance and fields such as rpoB, as well as how they intersect with chemical problems.
His primary areas of investigation include Tuberculosis, Mycobacterium tuberculosis, Mycobacterium tuberculosis complex, Drug resistance and Genetics. The concepts of his Tuberculosis study are interwoven with issues in Multiple drug resistance and Internal medicine. His biological study spans a wide range of topics, including Evolutionary biology, Whole genome sequencing, Antibiotic resistance, Isoniazid and Computational biology.
Stefan Niemann works mostly in the field of Mycobacterium tuberculosis complex, limiting it down to concerns involving Genotype and, occasionally, Microbiology and Antibiotics. His Drug resistance research is multidisciplinary, relying on both Pyrazinamide, Ethionamide, Ethambutol and Virology. As a part of the same scientific family, Stefan Niemann mostly works in the field of Genetics, focusing on INHA and, on occasion, Isoniazid resistance.
Stefan Niemann spends much of his time researching Tuberculosis, Mycobacterium tuberculosis, Mycobacterium tuberculosis complex, Drug resistance and Genetics. His Tuberculosis research is multidisciplinary, incorporating elements of Disease, Pediatrics and Cohort. His study in the fields of Mycobacterium africanum under the domain of Mycobacterium tuberculosis overlaps with other disciplines such as Extramural.
His work in Drug resistance addresses subjects such as Ethambutol, which are connected to disciplines such as Nanopore sequencing and Pyrazinamide. His studies in Genetics integrate themes in fields like Mycobacteria growth indicator tube and Isoniazid. His Genotyping research incorporates themes from Mycobacterium bovis, Variable number tandem repeat, Typing and Mycobacterium.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis
Philip Supply;Philip Supply;Caroline Allix;Sarah Lesjean;Sarah Lesjean;Mara Cardoso-Oelemann;Mara Cardoso-Oelemann.
Journal of Clinical Microbiology (2006)
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
Karine Brudey;Jeffrey R Driscoll;Leen Rigouts;Wolfgang M Prodinger.
BMC Microbiology (2006)
Variable host-pathogen compatibility in Mycobacterium tuberculosis.
Sebastien Gagneux;Kathryn DeRiemer;Tran Van;Midori Kato-Maeda.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
Iñaki Comas;Mireia Coscolla;Mireia Coscolla;Tao Luo;Sonia Borrell;Sonia Borrell.
Nature Genetics (2013)
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
Iñaki Comas;Jaidip Chakravartti;Peter M Small;James Galagan.
Nature Genetics (2010)
High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography.
Ruth Hershberg;Mikhail Lipatov;Peter M Small;Peter M Small;Hadar Sheffer.
PLOS Biology (2008)
Origin, Spread and Demography of the Mycobacterium tuberculosis Complex
Thierry Wirth;Falk Hildebrand;Caroline Allix-Béguec;Florian Wölbeling.
PLOS Pathogens (2008)
Correction: Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
Phelim Bradley;N. Claire Gordon;Timothy M. Walker;Laura Dunn.
Nature Communications (2016)
Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.
Iñaki Comas;Sonia Borrell;Sonia Borrell;Andreas Roetzer;Graham Rose.
Nature Genetics (2012)
Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
Roland Diel;Robert Loddenkemper;Karen Meywald-Walter;Stefan Niemann.
American Journal of Respiratory and Critical Care Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: